And neuroplasticity

STRESS, GLUCOCORTICOIDS AND NEUROPLASTICITY IN THE PATHOLOGY OF MOOD DISORDERS 895... 

D Sa C, Duman RS (2002) Antidepressants and neuroplasticity. Bipolar Disord 4 183-194 De Vry J (1995) 5-HTlA receptor agonists recent developments and controversial issues. Psychopharmacology (Berl) 121 1-26... 

Konradi C and Heckers S. Antipsychotic drugs and neuroplasticity Insights into the treatment and neurobiology of schizophrenia. Biol Psychiatry 2001 50 729-742. 

Taupin, P. (2006). Adult neurogenesis and neuroplasticity. Restor Neurol Neurosci, 24. 9-15. 

Mao, J. NMDA and opioid receptors their interactions in antinociception, tolerance and neuroplasticity, Brain Res. Rev. 1999, 30, 289-304. 

The time spent reviewing molecular neurobiology and neuroplasticity was about right. ... 

Pittenger C, Duman RS. Stress, depression, and neuroplasticity a convergence of mechanisms. Neuropsychopharmacology 2008 33 88-109. 

Crupi R, Marino A, Cuzzocrea S (2013) n-3 latty acids Role in neurogenesis and neuroplasticity. Curr Med Chem 20 2953-2963... 

Imaging Brain Signal Transduction and Neuroplasticity In Vivo... 

This critical review describes an experimental method and mathematical model to quanfily in vivo incorporation rates, half-lives, and turnover rates of FAs into brain phospholipids. FA incorporation is independent of cerebral blood flow and is thus a direct measure of brain phospholipid metabolism. Because specific FAs enter specific phospholipids at stereospecific positions, a combination of saturated and polyunsaturated FA labels can he used to investigate the active participation of phospholipids in brain signal transduction, membrane remodeling, and neuroplasticity. 

Rapoport SI, Purdon D, Shetty HU, Grange E, Smith Q. Jones C, et al. In vivo imaging of fatty acid incorporation into hrain to examine signal transduction and neuroplasticity involving phosphohpids. Ann NY Acad Sci 1997 820 56-74. 

Pessah IN. 1997. Non-coplanar PCBs alter neuronal Ca regulation and neuroplasticity by a FKBP12/ryanodine receptor-mediated mechanism. Toxicologist 36 333. 

Allian, H., Bentue-Ferrer, D., Gandon, J. M., LeDoze, F., Belliard, S. (1997). Drugs used in Alzheimer s disease and neuroplasticity. Clinical Therapeutics, 19, 4-15. 

Sessle B J (2000). Acute and chronic craniofacial pain Brainstem mechanisms of nociceptive transmission and neuroplasticity, and their clinical correlates. Crit. Rev. Oral Biol. Med. 11 57-91. 

Ando, S., Tanaka, Y., and Kon, K., 1986, Membrane aging of the brain synaptosomes with special reference to gangliosides, in Gangliosides and Neuroplasticity (G. Tettamanti, R. W. Ledeen, K. Sandhoff, Y. Nagai, and G. Taffano, eds.), Liviana Press, Podova, pp. 105-112. 

---